Marathon Pharmaceuticals LLC, a biopharmaceutical company focused on developing treatments for rare diseases and neurological disorders, named Babar Ghias its chief financial officer. In his new role, Ghias will have primary day-to-day responsibility for planning, implementing, managing and controlling all financial-related activities of the company. Ghias will also oversee corporate development activities for Marathon including transactions, financing, investor relations and the development ...